| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |